None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: We retrospectively analyzed patients diagnosed with gastric adenocarcinoma who underwent FL-guided minimally invasive gastrectomy at the Department of Surgery, Severance Hospital, Yonsei University Health System, Seoul, Korea, between August 2013 and December 2022.
Exclusion criteria
Exclusion criteria: Patients were excluded if they had: (1) distant metastasis, (2) a history of preoperative chemotherapy, (3) diffuse infiltrative or encircling tumors, (4) multiple lesions, (5) conversion to open surgery, or (6) missing station-level fluorescence data for any dissected LN station. Diffuse infiltrative, encircling, and multiple lesions were excluded because these features preclude the standardized four-quadrant peritumoral ICG injection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| number of patients with non-fluorescent metastatic lymph nodes | — |
Secondary
| Measure | Time frame |
|---|---|
| number of metastatic lymph nodes, number of patients with pathologic stage migration | — |
Countries
Korea, Republic of
Contacts
Yonsei University